Table: Wakamoto Pharm -2016/17 parent results

Wakamoto Pharmaceutical

12/05/2017 07:00

May 12 (Reuters)-  
          Wakamoto Pharmaceutical Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to        NEXT     
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018      YEAR       
                 LATEST         YEAR-AGO        COMPANY       COMPANY     
                 RESULTS         RESULTS       FORECAST     H1 FORECAST   
  Sales           10.83           11.18          10.93          5.37      
               (-3.2 pct)      (+4.2 pct)     (+0.9 pct)     (-2.2 pct)   
  Operating      87 mln          83 mln         100 mln     loss 140 mln  
               (+4.9 pct)      (-59.0 pct)    (+14.5 pct)                 
  Recurring      102 mln         124 mln        80 mln      loss 150 mln  
               (-17.6 pct)     (-46.5 pct)    (-22.3 pct)                 
  Net            94 mln          20 mln         30 mln      loss 110 mln  
              (+361.9 pct)     (-75.4 pct)    (-68.3 pct)                 
  EPS           2.73 yen        0.59 yen       0.86 yen    loss 3.17 yen  
  Ann Div       3.00 yen        3.00 yen                                  
  -Q2 Div          NIL             NIL                                    
  -Q4 Div       3.00 yen        3.00 yen                                  
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))